Grenco Science Announces Brand Partnership with BLLRDR, Canada’s Trailblazing Cannabis Brand


Ryan Allway

January 12th, 2021

News


The Exclusive Partnership with Grammy Award-Winning OVO Cofounder Noah “40” Shebib and Legendary Cultivator Jef Tek Marks G Pen’s First Partnership with a Canadian Cannabis Company

LOS ANGELESJan. 11, 2021 /PRNewswire/ — Grenco Science (G Pen) the leader in advanced technology cannabis vaporization, today announces a brand partnership with BLLRDR, the Toronto-based cannabis brand from Grammy award-winning OVO Cofounder Noah “40” Shebib and legendary cultivator Jef Tek.  BLLRDR is known for its extensive, market-leading cannabis genetics and small-batch production, developing rare and special cut strains. The groundbreaking partnership marks the first time G Pen has joined forces with a Canadian cannabis company.

The two industry leaders will introduce exclusive co-branded hardware and collaborate on the global line of G Pen advanced technology vaporizers. The BLLRDR x G Pen Dash is now available in select Ontario retailers and on bllrdrco.co. The release is well-timed with the launch of BLLRDR’s highly-anticipated Afghani Bullrider strain. Considered one of the rarest genetics on the market the strain is now officially available on the Ontario Cannabis Store.

Just like Afghani Bullrider, the high-performance BLLRDR x G Pen Dash Vaporizer delivers satisfying and flavourful results. The partnership will fully integrate the G Pen collaboration into BLLRDR’s retail and wholesale distribution in Canada and introduce product offerings nearly 20 years in the making.

G Pen, known for championing and celebrating the connection between consumption and art, is thrilled to partner with BLLRDR, Canada’s best new lifestyle cannabis brand, supporting its people and their mission. I’ve known Noah since the early stages of G Pen, and this partnership brings it full circle,” says G Pen CEO and Founder Chris Folkerts. “It’s an honor to be a part of the launch of the most highly-anticipated and unique genetics in the Ontario market.

“The BLLRDR ethos is rooted in innovation and from the beginning, a collaboration with G Pen has always been a goal. We truly respect the work they do to remain at the forefront of the vaporization space,” says Lorne Greenberg Co-founder and President of BLLRDR. “Working with 40 on our exclusive strains requires countless hours of engineering and perfecting. The G Pen team takes a very similar approach when developing their hardware, I can’t think of a more appropriate partner.”

The two companies have a shared history of innovation, helping to both elevate and advance the cannabis experience. After being diagnosed with multiple sclerosis, Shebib discovered the benefits of using the Afghani Bullrider strain. Tek’s late wife, medical marijuana activist Michelle Rainey, who suffered from Crohn’s disease and cancer, also found the strain offered relief from her symptoms.

Together they plan to bring sought-after collaborations to the market increasing the brand diversity of the popular G Pen vaporizers by integrating new cannabis products from BLLRDR with G Pen’s proprietary innovative technologies and hardware.

About Grenco Science
Grenco Science is a leader in engineering advanced cannabis vaporizers, setting new standards in aesthetics, portability, functionality, and user experience. Through proprietary research and development, as well as collaborations with influencers in music, art, and fashion, Grenco Science is transforming the cannabis experience and leading the movement to bring cannabis traditions to the 21st century. Visit gpen.com.

About BLLRDR
Toronto based cannabis brand house BLLRDR is bringing the finest curated strains to the legal market. Its inaugural strain is a collaboration between Grammy Award-winning producer and OVO co-founder Noah “40” Shebib, and legendary grower and breeder of Afghani Bullrider, Jef Tek. A strain favoured by Shebib for both its medicinal and recreational properties, Bullrider is extremely unique looking with a noticed high myrcene content, giving it a very distinct aroma and the effects that cannabis consumers desire. To cultivate their specialty strains, BLLRDR works in partnership with MJardin Group a leader in premium cannabis production.

For inquiries please contact:

Grenco Science
Jordan Goldstein, Director of Marketing
818.642.9890
jordan@grencoscience.com

Grenco Science media inquiries
Georgia Mack
917.916.6083
georgia@riopr.com

BLLRDR media inquiries
Liza McWilliams
Halo & Co.
liza@haloandco.co
416.802.986

SOURCE G Pen

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading